Literature DB >> 20701279

Redox reactions of the α-synuclein-Cu(2+) complex and their effects on neuronal cell viability.

Chengshan Wang1, Lin Liu, Lin Zhang, Yong Peng, Feimeng Zhou.   

Abstract

α-Synuclein (α-syn), a presynaptic protein believed to play an important role in neuropathology in Parkinson's disease (PD), is known to bind Cu(2+). Cu(2+) has been shown to accelerate the aggregation of α-syn to form various toxic aggregates in vitro. Copper is also a redox-active metal whose complexes with amyloidogenic proteins/peptides have been linked to oxidative stress in major neurodegenerative diseases. In this work, the formation of the Cu(2+) complex with α-syn or with an N-terminal peptide, α-syn(1-19), was confirmed with electrospray-mass spectrometry (ES-MS). The redox potentials of the Cu(2+) complex with α-syn-syn-Cu(2+)) and α-syn(1-19) were determined to be 0.018 and 0.053 V, respectively. Furthermore, the Cu(2+) center(s) can be readily reduced to Cu(+), and possible reactions of α-syn-Cu(2+) with cellular species (e.g., O(2), ascorbic acid, and dopamine) were investigated. The occurrence of a redox reaction can be rationalized by comparing the redox potential of the α-syn-Cu(2+) complex to that of the specific cellular species. For example, ascorbic acid can directly reduce α-syn-Cu(2+) to α-syn-Cu(+), setting up a redox cycle in which O(2) is reduced to H(2)O(2) and cellular redox species is continuously exhausted. In addition, the H(2)O(2) generated was demonstrated to reduce viability of the neuroblastoma SY-HY5Y cells. Although our results ruled out the direct oxidation of dopamine by α-syn-Cu(2+), the H(2)O(2) generated in the presence of α-syn-Cu(2+) can oxidize dopamine. Our results suggest that oxidative stress is at least partially responsible for the loss of dopaminergic cells in PD brain and reveal the multifaceted role of the α-syn-Cu(2+) complex in oxidative stress associated with PD symptoms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20701279      PMCID: PMC2939719          DOI: 10.1021/bi1010909

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  62 in total

1.  Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation.

Authors:  Andrés Binolfi; Gonzalo R Lamberto; Rosario Duran; Liliana Quintanar; Carlos W Bertoncini; Jose M Souza; Carlos Cerveñansky; Markus Zweckstetter; Christian Griesinger; Claudio O Fernández
Journal:  J Am Chem Soc       Date:  2008-08-09       Impact factor: 15.419

2.  Soluble amyloid beta1-28-copper(I)/copper(II)/Iron(II) complexes are potent antioxidants in cell-free systems.

Authors:  Rozena Baruch-Suchodolsky; Bilha Fischer
Journal:  Biochemistry       Date:  2008-07-04       Impact factor: 3.162

3.  Different species of alpha-synuclein oligomers induce calcium influx and seeding.

Authors:  Karin M Danzer; Dorothea Haasen; Anne R Karow; Simon Moussaud; Matthias Habeck; Armin Giese; Hans Kretzschmar; Bastian Hengerer; Marcus Kostka
Journal:  J Neurosci       Date:  2007-08-22       Impact factor: 6.167

4.  Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems.

Authors:  Rozena Baruch-Suchodolsky; Bilha Fischer
Journal:  Biochemistry       Date:  2009-05-26       Impact factor: 3.162

5.  Mechanism of hydrogen peroxide production by copper-bound amyloid beta peptide: a theoretical study.

Authors:  Nadine Hewitt; Arvi Rauk
Journal:  J Phys Chem B       Date:  2009-01-29       Impact factor: 2.991

6.  Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance.

Authors:  Dianlu Jiang; Lijie Men; Jianxiu Wang; Yi Zhang; Sara Chickenyen; Yinsheng Wang; Feimeng Zhou
Journal:  Biochemistry       Date:  2007-07-18       Impact factor: 3.162

Review 7.  Alzheimer's disease: from pathology to therapeutic approaches.

Authors:  Roland Jakob-Roetne; Helmut Jacobsen
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

8.  Metal binding to alpha-synuclein peptides and its contribution to toxicity.

Authors:  David R Brown
Journal:  Biochem Biophys Res Commun       Date:  2009-01-23       Impact factor: 3.575

9.  Changes in interfacial properties of alpha-synuclein preceding its aggregation.

Authors:  Emil Palecek; Veronika Ostatná; Michal Masarík; Carlos W Bertoncini; Thomas M Jovin
Journal:  Analyst       Date:  2007-10-15       Impact factor: 4.616

10.  Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers.

Authors:  Marcus Kostka; Tobias Högen; Karin M Danzer; Johannes Levin; Matthias Habeck; Andreas Wirth; Richard Wagner; Charles G Glabe; Sabine Finger; Udo Heinzelmann; Patrick Garidel; Wenzhen Duan; Christopher A Ross; Hans Kretzschmar; Armin Giese
Journal:  J Biol Chem       Date:  2008-02-07       Impact factor: 5.157

View more
  35 in total

1.  Membrane insertion exacerbates the α-Synuclein-Cu(II) dopamine oxidase activity: Metallothionein-3 targets and silences all α-synuclein-Cu(II) complexes.

Authors:  Jenifer S Calvo; Neha V Mulpuri; Alex Dao; Nabeeha K Qazi; Gabriele Meloni
Journal:  Free Radic Biol Med       Date:  2020-07-23       Impact factor: 7.376

2.  Coordination features and affinity of the Cu²+ site in the α-synuclein protein of Parkinson's disease.

Authors:  Christopher G Dudzik; Eric D Walter; Glenn L Millhauser
Journal:  Biochemistry       Date:  2011-02-14       Impact factor: 3.162

Review 3.  Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease.

Authors:  Aracely Garcia-Garcia; Laura Zavala-Flores; Humberto Rodriguez-Rocha; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2012-05-03       Impact factor: 8.401

4.  The Rich Electrochemistry and Redox Reactions of the Copper Sites in the Cellular Prion Protein.

Authors:  Feimeng Zhou; Glenn L Millhauser
Journal:  Coord Chem Rev       Date:  2012-05-04       Impact factor: 22.315

5.  Kinetic studies of inhibition of the amyloid beta (1-42) aggregation using a ferrocene-tagged β-sheet breaker peptide.

Authors:  Lin Zhang; Gargey Yagnik; Yong Peng; Jianxiu Wang; H Howard Xu; Yuanqiang Hao; You-Nian Liu; Feimeng Zhou
Journal:  Anal Biochem       Date:  2012-12-08       Impact factor: 3.365

Review 6.  Metals in Alzheimer's and Parkinson's Disease: Relevance to Dementia with Lewy Bodies.

Authors:  Erin J McAllum; David I Finkelstein
Journal:  J Mol Neurosci       Date:  2016-08-08       Impact factor: 3.444

7.  Copper redox cycling in the prion protein depends critically on binding mode.

Authors:  Lin Liu; Dianlu Jiang; Alex McDonald; Yuanqiang Hao; Glenn L Millhauser; Feimeng Zhou
Journal:  J Am Chem Soc       Date:  2011-07-18       Impact factor: 15.419

Review 8.  Antioxidant gene therapy against neuronal cell death.

Authors:  Juliana Navarro-Yepes; Laura Zavala-Flores; Annadurai Anandhan; Fang Wang; Maciej Skotak; Namas Chandra; Ming Li; Aglaia Pappa; Daniel Martinez-Fong; Luz Maria Del Razo; Betzabet Quintanilla-Vega; Rodrigo Franco
Journal:  Pharmacol Ther       Date:  2013-12-12       Impact factor: 12.310

9.  Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.

Authors:  Annadurai Anandhan; Humberto Rodriguez-Rocha; Iryna Bohovych; Amy M Griggs; Laura Zavala-Flores; Elsa M Reyes-Reyes; Javier Seravalli; Lia A Stanciu; Jaekwon Lee; Jean-Christophe Rochet; Oleh Khalimonchuk; Rodrigo Franco
Journal:  Neurobiol Dis       Date:  2014-12-08       Impact factor: 5.996

10.  Coordination of copper to the membrane-bound form of α-synuclein.

Authors:  Christopher G Dudzik; Eric D Walter; Benjamin S Abrams; Melissa S Jurica; Glenn L Millhauser
Journal:  Biochemistry       Date:  2012-12-26       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.